SPRB Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SPRB shares is 44, representing 48.64% of the company's common stock.

AIGH CAPITAL MANAGEMENT LLC, in the last quarter, reduced its stake in SPRB by -100% restricting it's holding to 0 shares of worth nearly N/A. BLACKROCK INC. also lessened -28.76% of the SPRB shares from its portfolio, reducing its holding to 185.95 thousand shares of worth $146.14K. TWO SIGMA INVESTMENTS, LP also shunned SPRB shares holding by -8.44% last quarter which brought its holding to 123.01 thousand shares worth $96.68K.

As per its latest 13F filing, ALTIUM CAPITAL MANAGEMENT LP increased its stake in SPRB by 100% in the last quarter. The institutional holder raised its holding to 1.15 million shares having worth more than $903.79K. PANAGORA ASSET MANAGEMENT INC also added 100% more shares of SPRB to its portfolio, raising its holding to 253.68 thousand shares of worth $199.37K. EXODUSPOINT CAPITAL MANAGEMENT, LP also increased its SPRB shares holding by 100% which brought its holding to 224.83 thousand shares worth $177.00K.

The insider with the most stakes in SPRB is Novo Holdings A/S , 10 percent owner at the company. Additionally, SPRB stock is highly held by director Chaya Moghrabi Dina and Omega Fund VI, L.P. among others.

Company executives, directors, and other insiders own 7.72% percent of Spruce Biosciences, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which SPRB insiders have sold stock, totaling 0 shares. Insiders that have sold shares include NOVO HOLDINGS A/S and SIMPSON CAMILLA V.

There have been 0 transaction(s) during the past 6-months in which Spruce Biosciences, Inc. insiders have bought stock, totalling 0 shares

Around 0 Spruce Biosciences, Inc. shares are held by insiders, which represents about 7.72% of SPRB stock.

SPRB 10 percent owner, Novo Holdings A/S holds the largest portfolio of the company's shares. SPRB shares owned by Novo total nearly 2.55 million.

AIGH CAPITAL MANAGEMENT LLC is the largest institutional owner in SPRB which holds 0 shares worth N/A or 0% of the total SPRB shares outstanding followed by ALTIUM CAPITAL MANAGEMENT LP with ownership of 1.15 million shares representing 2.8% of the SPRB ownership. PRIVIUM FUND MANAGEMENT (UK) LTD is the third largest stakeholder with 24.55 thousand shares or 0.06% of the ownership worth more than $20.13K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SPRB is concerned, it is a stock which is optionable.

Number of SPRB shares short is 248.99K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 41.30M shares of SPRB are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SPRB has 24.89M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SPRB is 0.98.